Home > Insider Trading > Filing (0001209191-15-007485)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505497	Biorestorative Therapies Inc.	BRTX	Services-Misc Health & Allied Services, Nec (8090)	911835664

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1038667	Ltd Bermuda Westbury	11 Victoria Street, P.o. Box Hm 1065 Hamilton D0 HMEX		No	No	Yes	No
1292286	Trust Westbury	11 Victoria Street, P.o. Box Hm 1065 Hamilton D0 HMEX		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-13	550,000	$0.00	2,665,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2014-12-31	450,000	$0.00	3,115,000	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2013-12-30	800,000	$0.00	800,000	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
800,000		2015-12-31	No	4	J	Indirect

Footnotes

On August 13, 2014, Westbury (Bermuda) Ltd. ("Westbury") agreed to extend the maturity date of certain notes issued by one of the wholly-owned subsidiaries of BioRestorative Therapies, Inc. (the "Issuer") in the aggregate principal amount of $4,000,000 (the "Notes") from July 31, 2014 to December 31, 2014. In consideration of the extension of maturity, the Issuer issued to Westbury 550,000 shares of the Issuer's common stock.
On December 31, 2014, Westbury agreed to extend the maturity date of the Notes from December 31, 2014 to June 30, 2015. In consideration of the extension of maturity, the Issuer issued to Westbury 450,000 shares of the Issuer's common stock.
These securities are directly owned by Westbury, which is 100% owned by Westbury Trust. Westbury Trust is an indirect beneficial owner of the reported securities.
The warrants were acquired in connection with the amendment to the exercise price of other warrants, which resulted in the deemed cancellation and replacement of such other warrants as was previously reported on a Form 4 filed with the SEC on January 2, 2014.
The warrants were exercisable immediately upon issuance.